News
From Period Tracking to Fertility: What Makes Women Use Health Apps

In the last decade, women’s health technology has come a long way. It began as rudimentary period and ovulation trackers, evolving into a highly developed fertility-focused platform with all sorts of services — cycle predictions to conception assistance.
Then what is causing this growth, and more importantly, what is it that makes women actually use these apps? In this article, I will analyze the key factors that influence the adoption and sustained engagement with women’s health platforms, drawing on experience from healthcare software development services to highlight best practices. Features to include in the application are drawn from usage statistics, user interviews, industry reports, app feature analysis, and so on. Core focus areas include:
- Evolution of femtech from period trackers to fertility tools
- Key drivers and needs spurring femtech adoption
- Factors influencing continued and increased usage
- Role of accuracy, privacy, access to experts, etc., in user retention
- How consumer needs are shifting from tracking to planning, prediction and intervention
- Market outlook, opportunities and challenges ahead
The Femtech Growth Trajectory
Femtech grew at a phenomenal rate from $250M in 2015 to around $39.29 billion in 2024. Women’s health technology has been going mainstream since the launch of the popular fertility app Glow in 2013, unicorn startups like Modern Fertility raising more than $160 million in funding, and everything in between.
But how did we get here? Let’s do a quick retrospective first.
The Beginnings – Period Tracking
For most female health apps on the market today, the journey began with period tracking. When Glow first debuted nearly a decade ago, it tapped into an unmet need for women to easily record and analyze their menstrual cycles using their smartphones.
Soon, similar apps such as Clue, Flo, Eve and so on started catching on, allowing women to log not only periods but also moods, symptoms, sexual activity and so on. However, the aggregation of this rich longitudinal data provided groundbreaking views of individual cycles and patterns, underscoring the importance of thoughtful healthtech UX in making that data both accessible and actionable.
It was obvious why – Flo had over 15 million downloads by 2016, and Clue had gotten almost 5 million users. The success of tracking-based apps was the beginning of the shape of women’s health tech that was yet to come.
Pregnancy Planning and Ovulation Tracking
Period trackers showed women their cycles, but the next steps were still left to be determined. The obvious next step was to develop these apps into forward-thinking planning tools designed to achieve things like preventing pregnancy or maximizing the chances of conception.
Since Ovia is a modern fertility app that not just gives a forecast of when you will be ovulating, period, but also provides personalized advice and analysis for effective family planning or getting pregnant faster. This allows users to log basal body temperature, cervical fluid consistency, intercourse details and more for more accuracy.
Many trackers now integrate with wearables and connected devices for passive data collection rather than relying solely on manual logging. They leverage predictive analytics and machine learning on the aggregate data to refine predictions and insights further.
The Market Expands – Fertility, Menopause and More
From ovulation and conception tools, femtech startups have diversified into adjacent women’s health segments:
- Fertility testing: Modern Fertility, EverlyWell, Natalist
- Menopause support: Genneve, Elektra Health
- Pelvic and sexual health: Minna Life, Elvie
- Pregnancy care: Peanut, Expectful
- General women’s wellness: Tia, Willow
Instead of just tracking cycles, these companies provide proactive health screenings, community support, telehealth access, and personalized care plans around issues like family planning, sexual wellness, pregnancy, menopause, and so on.
While some apps have retained an informational focus, newer entrants promise a combination of community support, telehealth access and even prescription delivery at home. The scope spans reproductive health, pregnancy, menopause and overall wellness.
So what exactly is propelling this femtech boom and persuading women to use these health apps? Let’s analyze some key drivers and consumer needs.
What’s Driving Femtech Adoption Among Women
The runaway success of femtech apps points to some clear unmet needs among women that this technology is serving. What core user requirements are these platforms addressing?
Need for Personalized Insights
Every woman’s cycle and reproductive health needs are unique. While medical guidelines exist, they provide blanket recommendations instead of tailored insights. Femtech apps fill this gap.
Personalized predictions and analysis come about through sophisticated algorithms that crunch individual tracking data against crowdsourced benchmarks. It allows women to decode their own patterns and preferences rather than depend on made-up assumptions.
The Desire to Be Proactive
Traditionally, women had to be reactive on reproductive health issues, whether by means of social taboos or medical norms. Using fertility apps enables them to take charge.
Instead of passively waiting for periods, pregnancies or menopause to happen unexpectedly, femtech apps allow women to foresee them and prepare mentally as well as physically.
Modern Fertility found that most of their users joined to understand their fertility proactively instead of waiting until they started trying or faced issues. The ability to drive their own health trajectories draws women to these platforms.
Need for Community Support
Reproductive experiences like pregnancy and menopause can feel emotionally isolating. Women often have nowhere to openly discuss concerns and challenges.
For instance, femtech apps that have community forums, such as Peanut and Gennev, offer solidarity and support from other women who are going through the same experience. A report by L.E.K. Consulting highlights that unmet needs in women’s health often include emotional support, particularly during pregnancy, postpartum, and reproductive health journeys. The apps turn out to serve a dual purpose — tracking health data and also serving as mental health assistance when required.
Convenience and Accessibility
Perhaps the most straightforward driver is that femtech apps offer low effort and high convenience. Instead of scheduling doctors’ visits, waiting for tests or taking time off work, essential health data, advice and interventions are available 24/7 on women’s phones.
Easy connectivity with wearables for automated data collection also minimizes the logging needed. Their usage often increases in tandem with the level of effortless tracking enabled.
The convenience quotient goes a notch higher with the ability to order testing kits, get prescriptions, and access experts online from home, apart from just monitoring cycles. Managing health is really lower than ever.
What keeps people engaged with these apps long term, once the appeal to women is made?
Factors Driving Sustained Usage of Femtech Apps
Though downloads are easy to attain, not all users are actively using health apps. Building trust is a key to retaining users. What exactly is it that makes women users keep coming back to femtech platforms from week to week?
Accuracy of Tracking and Predictions
“Garbage in, garbage out” applies strongly to data-driven femtech apps. Erroneous period or fertility forecasts will frustrate women instead of helping them. Builders have to continually refine accuracy by sourcing more data points and improving algorithms.
Apps explicitly show prediction precision to retain user trust. Flo displays monthly accuracy scores for period tracking. Proven test results and doctor reviews also reinforce reliability for fertility testing apps.
User feedback is open on the best platforms, which then use it to amend cycle analysis anomalies. To sustain usage, you have to show progress in precision through transparency.
Relevance of Recommendations
True generic wellness advice doesn’t pull you towards engaging. Femtech apps have to give specific suggestions for each woman’s reproductive profile and health objectives.
Period trackers can push appropriately timed exercise regimens, nutrition plans, self-care prompts, etc., based on where users are in their cycle. Apps also educate women on high fertility days, early pregnancy precautions, menopause management, and more based on phase-specific needs.
Personalization requires synthesizing their tracked data, stated goals and contextual information like age, weight, health conditions, etc. Actionable and relevant recommendations specific to the user keep women checking back in.
Holistic Support Across Needs
Across life stages, women’s needs change from contraception to conception aid to menopause support. This aligns with this changing requirement, which encourages prolonged usage instead of single-purpose apps.
For instance, Tia started as a period/ovulation tracker but now also offers gynecological care, sexual health, pregnancy support, postpartum care and menopause services. Ovia’s suite of apps covers different stages like pregnancy, parenting and fertility.
Femtech apps positioned as long-term partners in women’s health win more loyalty compared to point solutions.
Access to Health Experts
While period and ovulation trackers are a great foundation for data, women usually need professional help to understand the implications.
Direct access to gynecologists, reproductive endocrinologists, pelvic floor therapists, mental health professionals, etc., through chat/call features builds credibility for femtech apps. It also fosters emotional reassurance when dealing with sensitive concerns.
Modern Fertility provides free 30-minute consults with fertility nurses to users. Others, like Minna Life and Genneve, enable in-app physician appointments. The convenience of expert medical advice, without appointments or clinic visits, keeps women returning.
Sense of Security and Privacy
In particular, privacy and data security are key to user comfort when dealing with intimate information such as cycles, sexual activity, contraception, pregnancy, etc.
Even the most useful apps risk being abandoned if they are hacked, data is leaked, or shared with concerns. Reassuring users proactively and explaining safety precautions in place results in more peace of mind.
Femtech apps include encryption methods, access controls and transparency on how data is used, and even include the ability to delete past entries irretrievably. Maintaining people’s sensitive medical history securely earns their ongoing reliance.
The Path Ahead for Femtech
Although women’s health technology has achieved widespread success, its use cases and market potential remain largely unexplored. However, some pertinent opportunities and challenges exist ahead.
Evolution from Tracking to Treatment
The end goal for femtech cannot be just monitoring and predicting reproductive health. True value addition will require helping women intervene in and improve their outcomes proactively.
This is the path forward: Modern Fertility’s entrance into personalized fertility treatment plans based on assessments. Apps will go beyond tracking to include prescription drugs, hormonal therapies delivered at home, at-home insemination tools, remote menopause counseling, and many more.
Preventive and corrective health will be the next frontier.
Overcoming Drop-Offs
The biggest threat to femtech’s future is abandonment after initial interest. Period-tracking app users stop engaging after three months at a rate of 72 percent. Principal drop-off drivers include privacy concerns, burden overhead, poor predictions, no actionability, and no support when vulnerable.
For the extended life, this will drive continued usage and therefore require ongoing value through better data integrations, personalized engagement features, and access to care. Alignment of early attrition risks and correcting them will be vital.
Operationalizing Robust Research
Femtech apps have access to very rich fertility health data at scale from millions of women around the world. The data capital contained in this has the potential to accelerate new reproductive research and insights faster than ever.
However, we must systematically operationalize the research potential, utilizing in-house experts and forming partnerships with university labs, hospitals, and biopharma companies. Here, data security and commercialization opportunities are both needed.
Responsible forging of robust medical research partnerships will open the doors to biomarkers of disease and early interventions, and much more.
Aligning with Evolving Market Needs
Women’s health needs are diverse and ever-evolving. The femtech market has expanded across subcategories like pregnancy tech, menopause tech and more. Continued fragmentation is imminent as startups spot newer micro opportunities.
But if they confuse users, this also runs the risk of confusing users. Consequently, apps must be specialized and simultaneously integrated across categories in accordance with what the user wants. Even while expanding the scope, the fundamental promise to women must be fulfilled.
Conclusion
Overall, femtech has been adopted because it addresses women’s need for personalized and proactive health insights. Retention is proving critical as convenience, community and access to care during vulnerable times.
However, data no longer needs to be overly passively tracked. We need a future, and enabling interventions by intelligent predictions, prescriptions, and expert guidance is necessary. Another bucket of potential will be unlocked by data security and partnerships.
As femtech builders expand their scope, they must remain in alignment with the core requirements of accuracy, convenience, and access to care for women. The promise of data-driven women’s health is only going to be delivered against these pillars.
The beginning of transforming medical outcomes by putting control directly in women’s hands. It is an exciting time for the consumers and creators of femtech solutions.
Pregnancy
Pregnant women may reduce key health risk through more light exercise, study finds

Light exercise and less sitting may reduce pregnant women’s risk of serious blood pressure complications, according to a new study.
Researchers have proposed a daily activity and sleep guide that they say was linked to a nearly 30 per cent lower risk of hypertensive disorders of pregnancy.
The suggested pattern includes fewer than eight hours of sedentary time, at least seven hours of light physical activity, around 22 minutes of more intense activity and nearly nine hours of sleep.
The University of Iowa-led study examined the daily behaviours of 470 pregnant women across all stages of pregnancy.
Participants wore monitors that measured physical activity over 24-hour periods and recorded how long they spent asleep.
Hypertensive disorders of pregnancy include chronic high blood pressure, gestational hypertension and pre-eclampsia.
Gestational hypertension is high blood pressure that develops during pregnancy, while pre-eclampsia is a potentially serious condition involving high blood pressure and signs that organs may be affected.
Sedentary behaviour means being mostly inactive, such as sitting or lying down.
Light physical activity can include casual walking, moving around the home or standing.
Moderate to vigorous activity includes movement such as brisk walking, where breathing and heart rate increase.
Kara Whitaker, associate professor in the department of health, sport, and human physiology at Iowa and corresponding author of the study, said: “We are identifying the optimal composition of movement behaviours across the day associated with the lowest risk of developing HDP and the most improved health outcomes.
“This blueprint holds for each and every trimester of pregnancy.”
Study participants were enrolled at sites in Iowa City, Pittsburgh and Morgantown, West Virginia.
The women wore activity and sleep monitors for at least one week during each trimester of pregnancy.
Four in five participants were non-Hispanic white and nearly a quarter lived in rural areas.
The data showed a steep rise in risk among pregnant women who were sedentary for more than 10 hours a day.
Women who increased light physical activity to at least four hours a day reduced their risk of hypertensive disorders of pregnancy to 15 per cent from 30 per cent.
Whitaker said: “Just moving around more seems to have significant health benefits.
“And I think it also may be a more feasible target for women who are pregnant who are not exercising regularly.”
The researchers said they were surprised that longer durations of moderate to vigorous physical activity did not appear to provide additional benefit.
Sleep beyond a certain duration also did not appear to bring major further benefits.
Whitaker said: “Through this study, we are providing evidence that reducing sedentary behaviour and engaging in light physical activity are important, and maybe more important, when it comes to pregnancy and health.”
The findings may be relevant beyond pregnancy because clinical research has shown that women who develop hypertensive disorders of pregnancy are more than twice as likely to develop heart disease later in life.
Cardiovascular disease includes conditions affecting the heart and blood vessels, such as heart disease and stroke.
Whitaker said: “We know that cardiovascular disease is the number one killer of women, and if we can intervene in pregnancy and prevent women from developing a hypertensive disorder of pregnancy, we are putting them on a better trajectory, away from cardiovascular disease and toward more optimal cardiovascular health.”
The study was published online on June 10.
A second study, published online on May 27, looked more closely at the ratio and type of sedentary behaviour and light physical activity linked to a lower risk of hypertensive disorders of pregnancy.
Whitaker is a lead co-author on that study.
Co-authors in the June 10 study include Alex Crisp, Jaemyung Kim, Karina Smith, Donna Santillan, Mark Santillan and Bridget Zimmerman, from Iowa; Jacob Gallagher, from Iowa State University; Melissa Jones, from Oakland University in Michigan; Bethany Barone Gibbs, Katrina Wilhite, Alexis Thrower and Iqra Sheikh, from West Virginia University; and Sabera Rahman, Janet Catov, Christopher Kline and Maisa Feghali, from the University of Pittsburgh.
The National Institutes of Health, the University of Iowa Institute for Clinical and Translational Science, the University of Pittsburgh Clinical and Translational Science Institute and the West Virginia Clinical and Translational Science Institute funded the research.
News
Femtech World Awards 2026: Winners revealed

We are excited to reveal the winners of the third annual Femtech World Awards.
The winners were announced at a virtual event this afternoon attended by shortlisted companies, along with sponsors and judges.
The event welcomed guests from the UK, Europe, Asia, Africa and North America.
Thank you to all 174 entries, as well as the sponsors for making the event possible.
See you in 2027!
Femtech World Awards 2026 Winners

Winner:
Shortlisted:
IVI RMA x Juno Genetics
Natural Cycles

Winner:
Highly commended:
U-Ploid
Shortlisted:
Hello Inside

Winner:
WISE HF, led by Prof. Mary Ryder
Highly commended:
Cardiac College for Women
Shortlisted:
Hyvelle Ferguson-Davis
CognitiveCare

Winner:
Highly commended:
Youterus
Shortlisted:
ŌURA

Winner:
Shortlisted:
LeanShield by ParrotPal Group
Perigen

Winner:
Shortlisted:
Body Moody
Looop

Winner:
Shortlisted:
Owning Your Menopause
Womeno

Winner:
Shortlisted:
The Blue Box
Celbrea

Winner:
Shortlisted:
HealCycle
Mor

Winner:
Shortlisted:
HRC Fertility
Mira
Motherhood
Expectations about sleep affect postpartum sleep quality, study finds

Pregnant women’s expectations about postpartum sleep may predict sleep quality after birth, outweighing prior sleep and psychiatric history, a study suggests.
The findings suggest attitudes and beliefs about sleep during pregnancy could be a modifiable risk factor for postpartum sleep concerns.
They also indicate that, among women expecting the poorest sleep, higher postpartum anxiety may further worsen sleep quality.
Sammy Dhaliwal, lead author is clinical health psychologist and research fellow in the department of obstetrics and gynaecology at the Perelman School of Medicine at the University of Pennsylvania.
Dhaliwal said: “Most pregnant women in our sample anticipated poor postpartum sleep before it occurred, and it was striking that those expectations predicted worse sleep outcomes even after accounting for factors such as prior sleep disorders, psychiatric history, and number of previous births.
“This suggests that attitudes and beliefs about sleep during pregnancy may represent a modifiable target for early intervention before postpartum sleep problems emerge.”
Sleep disturbance affects an estimated 60 to 80 per cent of postpartum women and is linked to a higher risk of depression and anxiety.
Researchers said it is often regarded as an expected part of life after childbirth rather than a health issue that may be addressed earlier.
The study enrolled 432 pregnant women at about 24 weeks of gestation, meaning around 24 weeks into pregnancy.
Participants completed measures of their expectations about postpartum sleep, current sleep quality using the Pittsburgh Sleep Quality Index, and mood using validated depression and anxiety scales.
Assessments were repeated at six, 12 and 24 weeks postpartum.
A subset of 49 women also wore wrist actigraphy devices at six to eight weeks postpartum.
Actigraphy uses a wearable device, similar to a watch, to estimate sleep and wake patterns based on movement.
The results showed that 70 per cent of pregnant women, or 301 of 432 participants, expected poor sleep in the postpartum period.
Researchers found that predicted sleep disruption during pregnancy was a significant predictor of postpartum sleep concerns.
Among first-time pregnant women without prior health concerns, those who expected greater sleep disturbance had significantly more disrupted sleep after birth, measured by both actigraphy and self-report.
Among women who expected the worst sleep quality, higher postpartum anxiety significantly worsened both measured sleep and self-reported sleep, independent of anxiety levels during pregnancy.
Dhaliwal said the findings point to two possible areas for intervention: addressing sleep-related beliefs during pregnancy and treating postpartum anxiety.
Dhaliwal said: “Postpartum sleep disruption is often treated only after problems develop, but our findings suggest there may be an opportunity to intervene earlier during pregnancy.
“Addressing sleep-related beliefs and postpartum anxiety during prenatal and postpartum care may help improve sleep and emotional well-being in new mothers.”
Menopause3 weeks agoPerimenopause misinformation ‘putting women at risk’
Hormonal health3 weeks agoNHS urged to update website following renaming of PCOS
News2 weeks agoWomen still being failed when they reach menopause, experts say
Events2 weeks agoWomen’s Health Innovation Summit opens submissions for 2026 Innovation Showcase
Insight1 week agoBritish women among angriest in Europe, health survey reveals
News2 weeks agoThree menopause innovators shortlisted for Femtech World Award
Fertility4 weeks agoAI could transform ovarian care through personalisation, study finds
News3 weeks agoLow insulin diet and avoiding four food groups may prevent menopause weight gain
















